184.07
전일 마감가:
$181.44
열려 있는:
$182.3
하루 거래량:
736.91K
Relative Volume:
0.78
시가총액:
$20.58B
수익:
$10.52B
순이익/손실:
$999.00M
주가수익비율:
22.01
EPS:
8.3628
순현금흐름:
$1.22B
1주 성능:
+2.64%
1개월 성능:
+2.18%
6개월 성능:
+12.34%
1년 성능:
+24.53%
퀘스트 다이아그노스틱스 Stock (DGX) Company Profile
명칭
Quest Diagnostics Inc
전화
(973) 520-2700
주소
500 PLAZA DRIVE, SECAUCUS
DGX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
DGX
Quest Diagnostics Inc
|
184.07 | 20.29B | 10.52B | 999.00M | 1.22B | 8.3628 |
![]()
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
![]()
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
![]()
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
![]()
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
퀘스트 다이아그노스틱스 Stock (DGX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-08-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2025-04-02 | 개시 | Redburn Atlantic | Buy |
2025-03-04 | 다운그레이드 | Citigroup | Buy → Neutral |
2025-01-06 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
2024-12-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2024-12-10 | 재개 | Jefferies | Buy |
2024-10-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2024-08-28 | 재개 | Evercore ISI | In-line |
2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
2024-02-26 | 개시 | Leerink Partners | Market Perform |
2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
2024-01-03 | 개시 | Barclays | Equal Weight |
2023-12-12 | 업그레이드 | BofA Securities | Neutral → Buy |
2023-06-29 | 개시 | Piper Sandler | Neutral |
2023-05-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
2023-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
2023-01-23 | 개시 | Evercore ISI | In-line |
2022-11-17 | 다운그레이드 | Citigroup | Neutral → Sell |
2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
2022-04-04 | 다운그레이드 | Citigroup | Buy → Neutral |
2022-02-23 | 다운그레이드 | UBS | Buy → Neutral |
2022-02-02 | 다운그레이드 | Jefferies | Buy → Hold |
2022-01-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
2021-05-04 | 업그레이드 | UBS | Neutral → Buy |
2021-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2020-10-21 | 업그레이드 | Argus | Hold → Buy |
2020-07-29 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-07-14 | 업그레이드 | BofA Securities | Neutral → Buy |
2020-06-09 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
2020-06-02 | 업그레이드 | Deutsche Bank | Hold → Buy |
2020-04-28 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2020-04-27 | 업그레이드 | Citigroup | Neutral → Buy |
2020-04-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
2020-03-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2020-01-08 | 개시 | Wells Fargo | Underweight |
2020-01-07 | 다운그레이드 | Barclays | Overweight → Equal Weight |
2019-12-19 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
2019-07-15 | 다운그레이드 | Goldman | Neutral → Sell |
2019-04-02 | 업그레이드 | Jefferies | Hold → Buy |
2019-03-18 | 재개 | Credit Suisse | Neutral |
2019-01-31 | 다운그레이드 | Argus | Buy → Hold |
2019-01-17 | 개시 | UBS | Neutral |
2019-01-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
2018-12-03 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
2018-11-30 | 다운그레이드 | Goldman | Buy → Neutral |
모두보기
퀘스트 다이아그노스틱스 주식(DGX)의 최신 뉴스
Ranking Quest Diagnostics Incorporated among high performing stocks via toolsBuy Signal & Weekly Setup with ROI Potential - newser.com
Trend analysis for Quest Diagnostics Incorporated this weekAnalyst Upgrade & Consistent Profit Focused Trading Strategies - newser.com
Q3 EPS Estimate for Quest Diagnostics Decreased by Analyst - MarketBeat
Rice Partnership LLC Invests $3.33 Million in Quest Diagnostics Incorporated $DGX - MarketBeat
Game Plan Financial Advisors LLC Cuts Position in Quest Diagnostics Incorporated $DGX - MarketBeat
How to read the order book for Quest Diagnostics Incorporated2025 Market Sentiment & Safe Entry Point Alerts - newser.com
Can Quest Diagnostics Incorporated stock sustain breakout momentumSwing Trade & Free Weekly Watchlist of Top Performers - newser.com
Vontobel Holding Ltd. Boosts Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
How Quest Diagnostics Incorporated (QDI) stock responds to job market shifts2025 Top Gainers & AI Enhanced Execution Alerts - newser.com
Can Quest Diagnostics Incorporated (QDI) stock retain market dominanceMarket Sentiment Report & Technical Pattern Alert System - newser.com
Quest Diagnostics' (DGX) Buy (B) Rating Reiterated at Weiss Ratings - MarketBeat
Will Quest Diagnostics Incorporated stock hit analyst forecastsJuly 2025 PostEarnings & Safe Entry Trade Reports - newser.com
What macro factors could drive Quest Diagnostics Incorporated stock higher2025 Key Lessons & Safe Investment Capital Preservation Plans - newser.com
Bar Harbor Wealth Management Invests $2.73 Million in Quest Diagnostics Incorporated $DGX - MarketBeat
Janney Montgomery Scott LLC Has $3.62 Million Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Evercore ISI Group Raises Price Target for Quest Diagnostics (DG - GuruFocus
Quest Diagnostics (NYSE:DGX) Price Target Raised to $190.00 - MarketBeat
Evercore ISI Adjusts Price Target on Quest Diagnostics to $190 From $185, Maintains In Line Rating - MarketScreener
Leerink Partners Adjusts Price Target on Quest Diagnostics to $203 From $192, Maintains Outperform Rating - MarketScreener
How Quest Diagnostics Incorporated (QDI) stock reacts to stronger dollarMarket Growth Report & Technical Analysis for Trade Confirmation - newser.com
Is Quest Diagnostics Incorporated (QDI) stock a top pick for value investorsJuly 2025 Movers & Low Drawdown Momentum Ideas - newser.com
2,014 Shares in Quest Diagnostics Incorporated $DGX Purchased by Gratus Wealth Advisors LLC - MarketBeat
Appleton Partners Inc. MA Boosts Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Knights of Columbus Asset Advisors LLC Purchases 2,526 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
OLD National Bancorp IN Raises Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Why Quest Diagnostics Incorporated stock could rally stronglyJuly 2025 Outlook & Technical Pattern Alert System - newser.com
Will Quest Diagnostics Incorporated continue its uptrend2025 Top Decliners & AI Based Buy and Sell Signals - newser.com
Quest Diagnostics Incorporated stock daily chart insightsJuly 2025 Market Mood & AI Driven Stock Price Forecasts - newser.com
Quest Diagnostics: Investing In Healthcare's Future Today (NYSE:DGX) - Seeking Alpha
How Quest Diagnostics Incorporated (QDI) stock behaves in tightening cycles2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
Evaluating Quest Diagnostics Incorporated with trendline analysis2025 Price Momentum & Smart Money Movement Tracker - newser.com
Technical analysis overview for Quest Diagnostics Incorporated stockTrade Risk Report & Community Consensus Stock Picks - newser.com
What to expect from Quest Diagnostics Incorporated in the next 30 daysWeekly Profit Recap & Verified High Yield Trade Plans - newser.com
74,250 Shares in Quest Diagnostics Incorporated $DGX Bought by Boston Common Asset Management LLC - MarketBeat
QRG Capital Management Inc. Buys 11,008 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
J. Safra Sarasin Holding AG Grows Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term - sharewise.com
Is Quest Diagnostics' (DGX) Shield Partnership Transforming Its Role in Preventive Health Innovation? - Yahoo Finance
Copeland Capital Management LLC Has $31.66 Million Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
How Quest Diagnostics Incorporated (QDI) stock moves in volatile trading sessionsJuly 2025 Summary & Real-Time Volume Triggers - newser.com
Analyzing Quest Diagnostics Incorporated with multi timeframe chartsPortfolio Growth Summary & Community Verified Trade Signals - newser.com
State of Alaska Department of Revenue Has $2.25 Million Stock Position in Quest Diagnostics Incorporated $DGX - Defense World
Barclays Maintains Quest Diagnostics (DGX) Equal-Weight Recommendation - Nasdaq
Quest Diagnostics Hits New 52-Week High of $189.23, Reflecting Strong Performance - Markets Mojo
Barclays Raises Price Target for Quest Diagnostics (DGX) to $190 - GuruFocus
Barclays Adjusts Price Target on Quest Diagnostics to $190 From $185, Maintains Equalweight Rating - MarketScreener
USA Financial Formulas Makes New Investment in Quest Diagnostics Incorporated $DGX - MarketBeat
1,532 Shares in Quest Diagnostics Incorporated $DGX Acquired by GC Wealth Management RIA LLC - MarketBeat
퀘스트 다이아그노스틱스 (DGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
퀘스트 다이아그노스틱스 주식 (DGX) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
PREVOZNIK MICHAEL E | SVP & General Counsel |
Sep 26 '25 |
Sale |
188.13 |
227 |
42,706 |
38,117 |
자본화:
|
볼륨(24시간):